Atlas Trials

Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT00961038 · COMPLETED

Trial details

NCT number
NCT00961038
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2009-08-01
Primary completion
2010-03-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.